Anti-EBV-CA IgM and anti-EBV-EA(D) IgG antibodies were more prevalent in RA patients than in controls (19% vs. 2%, p = 0.003 and 19% vs. 6%, p = 0.025, respectively). This evidence concerns the gene CD40LG and rheumatoid arthritis.